Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts-Reference-Cited by-同舟云学术

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

Published:2020-06-09 Issue:8 Volume:40 Page:1841-1852
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Mangia Alessandra¹^ORCID,Milligan Scott²,Khalili Mandana³^ORCID,Fagiuoli Stefano⁴,Shafran Stephen D.⁵,Carrat Fabrice⁶,Ouzan Denis⁷,Papatheodoridis George⁸^ORCID,Ramji Alnoor⁹,Borgia Sergio M.¹⁰,Wedemeyer Heiner¹¹^ORCID,Losappio Ruggero¹²,Pérez‐Hernandez Francisco¹³,Wick Nicole²,Brown Robert S.¹⁴,Lampertico Pietro¹⁵^ORCID,Doucette Karen⁵,Ntalla Ioanna¹⁶,Ramroth Heribert¹⁶,Mertens Michael¹⁶,Vanstraelen Kim¹⁶,Turnes Juan¹⁷

Affiliation:

1. IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo Italy

2. Trio Health Analytics La Jolla CA USA

3. University of California San Francisco San Francisco CA USA

4. Papa Giovanni XXIII Hospital Bergamo Italy

5. University of Alberta Edmonton Canada

6. Sorbonne UniversitéINSERMInstitut Pierre Louis Epidémiologie et Santé PubliqueAPHP.Sorbonne Université Paris France

7. Institut Arnault Tzanck Saint‐Laurent‐du‐Var France

8. National and Kapodistrian University of Athens Athens Greece

9. University of British Columbia Vancouver Canada

10. William Osler Health System Brampton Canada

11. University Clinic Essen Essen Germany

12. Vittorio Emanuele II Hospital Bisceglie Italy

13. Hospital Universitario Nuestra Señora de Candelaria Santa Cruz Spain

14. Weill Cornell MedicineDepartment of Medicine New York City USA

15. Fondazione IRCCS Ca’ GrandaOspedale Maggiore PoliclinicoUniversity of Milan Milan Italy

16. Gilead Sciences Europe Ltd Stockley Park United Kingdom

17. Department of Gastroenterology and Hepatology C.H.U. Pontevedra and IIS Galicia Sur Pontevedra Spain

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14537

Reference35 articles.

1. World Health Organization.Global health sector strategy on viral hepatitis 2016–2021: towards ending viral hepatitis.2016.https://apps.who.int/iris/bitstream/handle/10665/246177/WHO‐HIV‐2016.06‐eng.pdf?sequence=1. Accessed April 2020

2. EASL Recommendations on Treatment of Hepatitis C 2018

3. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry

4. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

5. World Health Organization.Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection.2018.https://apps.who.int/iris/bitstream/handle/10665/273174/9789241550345‐eng.pdf?ua=1. Accessed April 2020

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Influence of Treatment With Sofosbuvir/Velpatasvir on Children’s Growth—Results of the PANDAA-PED Study;Pediatric Infectious Disease Journal;2024-09-04

2. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

3. Identifying Gaps in the Treatment Guidelines for Hepatitis C in Peru to Meet International Standards: A Narrative Review;Journal of Clinical Medicine;2024-06-30

4. Key points for the management of hepatitis C in the era of pan-genotypic direct-acting antiviral therapy;Exploration of Digestive Diseases;2024-06-18

5. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02